To gain an initial indication of these candidate genes in prostate cancer, the expression levels of CASP3, BMP5 and IRS2 in three most commonly used human prostate cancer cell lines, namely LNCaP, DU 145 and PC-3, were examined using real-time RT-PCR (Figure 2). This evidence concerns the gene IRS2 and Familial prostate cancer.